INTRODUCTION
============

Intensivists are physicians who specialize in the care of critically ill patients and are trained to manage all aspects of the intensive care unit (ICU) stay ([@B1][@B2]). Intensivists improve the clinical outcomes of critically ill patients ([@B3][@B4][@B5]). Neurointensivists are specialists focused on the management of patients with acute neurologic conditions including traumatic brain injury (TBI), stroke, status epilepticus, and neuromuscular respiratory failure ([@B6][@B7][@B8]). Despite several studies of outcome prediction in general and surgical ICUs, high-intensity ICUs managed by neurointensivists are not common in many hospitals ([@B7][@B8][@B9]). Limited data are available regarding prediction of outcomes in neuroscience ICUs ([@B4][@B7][@B10]). Several studies reported improved outcomes by neurointensivists, including decreased mortality rates, shortened lengths of ICU and hospital stay in patients with TBI, intracranial hemorrhage, and subarachnoid hemorrhage ([@B2][@B3][@B9][@B11][@B12]). However, the impact of neurointensivists and improved outcome in neuroscience ICUs in Korea has not been evaluated. This is the first report of the role of neurointensivists and clinical outcomes after initiation of neurointensivist co-management in neurosurgical intensive care units (NSICUs) in Korea. In this study, we evaluated the impact of neurointensivist co-management on outcomes in patients admitted to a NSICU.

MATERIALS AND METHODS
=====================

Study population
----------------

This was a retrospective, single-center, observational study of neurocritically ill patients and neurosurgical patients who were admitted to the NSICU at the Samsung Medical Center between March 2013 and May 2016. The patients admitted to the NSICU were considered for this study. Patients were excluded if they were admitted to departments other that neurosurgery or had not neurological problems. We also excluded the patients who were transferred to departments other that neurosurgery during ICU hospitalization because factors other than neurosurgical team and neurointensivist might have influenced the result of this study. In addition, we excluded in this analysis the patients with elective surgery such as brain tumor surgery, elective vascular surgery, microvascular decompression, epileptic surgery, elective spinal surgery, or surgery of congenital anomaly.

Definitions and outcomes
------------------------

The NSICU was independently operated and separated from the neurology and general surgery ICUs in this study. Neurointensivist co-management was initiated on October 1 2014. During the neurointensivist co-management period, the neurointensivist worked 6 days per week during the daytime. The neurocritical care team consisted of an attending neurointensivist, neurosurgical resident, and consultant pharmacist. The consultant pharmacist advised the neurocritical care team on pharmaceutic issues by phone after morning rounds. Neurointensivist was involved in general critical managements, including hemodynamic monitoring, nutritional support, and use of mechanical ventilation, renal replacement therapy, etc. Neurosurgeon was responsible for surgical management. However, neurosurgeon discussed important decisions with neurointensivist in neurocritical management such as control strategy of increased intracranial pressure and neuromonitoring methods. Although the neurosurgical team discussed the treatment plans of all ICU patients with the neurointensivist, the leader of the neurosurgical team was responsible for the patients and determined their transfer from the ICU to the neurosurgical ward in this study. The neurointensivist managed all aspects of these neurosurgical patients during their ICU hospitalization. In addition, the neurointensivist evaluated and managed neurosurgical patients by lung sonography, echocardiography and bronchoscopy, together with neurocritical management. The neurointensivist also implemented central venous catheterization and peripherally inserted central catheterization, endotracheal intubation, percutaneous dilatational tracheostomy, etc. The neurointensivist had educated neurosurgical residents and monitored procedures performed by the residents in the ICU. Furthermore, the neurointensivist consulted for patients in the neurosurgical ward who had hemodynamic instability or respiratory problem.

The initial Glasgow Coma Scale (GCS) was defined as the best GCS within 24 hours of ICU admission. Severity of illness was assessed by the Acute Physiology and Chronic Health Evaluation II (APACHE II) score ([@B13]).

We compared the outcomes of neurosurgical patients admitted before and after initiation of mandatory neurointensivist co-management in the NSICU. Subgroup analysis was performed as causes of ICU admission such as TBI, intracranial hemorrhage, subarachnoid hemorrhage, and cerebral infarction. We analyzed TBI patients on ICU admission or preoperative state. TBI patients were assessed by using International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) prognostic model and APACHE II score ([@B14][@B15]). Brain computed tomography (CT) finding was accessed according to the Marshall CT scan classification system in TBI patients ([@B16]).

The primary endpoint was ICU mortality. Secondary endpoints were 30-day mortality and length of stay (LOS) in the ICU.

Statistical analysis
--------------------

All data are presented as means ± standard deviations (SD) for continuous variables and as numbers (percentages) for categorical variables. Data were compared using Student\'s t-test for continuous variables and the χ^2^ test or Fisher\'s exact test for categorical variables. The Kaplan-Meier method was used to generate survival curves, which were compared using log-rank test. Multiple logistic regression analysis was used to identify independent predictors of survival in neurocritically ill patients, as measured by the estimated odds ratio (OR) with 95% confidence intervals (CIs). Variables with a *P* value less than 0.2 on univariate analyses, as well as a priori variables that were clinically relevant, were entered into the multiple logistic regression model. All tests were 2-sided, and *P* values \< 0.05 were considered to indicate statistical significance. Data were analyzed using SPSS statistics version 20 (IBM, Armonk, NY, USA).

Ethics statement
----------------

This was a retrospective, single-center, observational study of neurocritically ill patients and neurosurgical patients who were admitted to the NSICU at the Samsung Medical Center between March 2013 and May 2016. The study was approved by the Institutional Review Board of Samsung Medical Center (IRB No. SMC 2016-08-126-001) to review and publish information from patients\' records. The requirement for informed consent was waived because of the retrospective nature of the study.

RESULTS
=======

Baseline characteristics
------------------------

A total of 3,683 patients was admitted to the NSICU during the study period. The patients with elective surgery and were transferred to departments other that neurosurgery during ICU hospitalization were excluded. Finally, 571 patients were analyzed in this study; 291 prior to initiation of neurointensivist co-management and 280 thereafter. The mean age was 58.2 ± 19.0 years, and 306 patients (53.6%) were men. Intracranial hemorrhage (29.6%) and TBI (26.6%) were the most common reasons for ICU admission. There were no significant differences in gender, comorbidities, causes of ICU admission, and GCS and APACHE II score on ICU admission between before and after neurointensivist co-management ([Table 1](#T1){ref-type="table"}).

###### Baseline characteristics on ICU admission before and after neurointensivist co-management

![](jkms-32-1024-i001)

  Parameters                         Before (n = 291)   After (n = 280)   *P* value
  ---------------------------------- ------------------ ----------------- -----------
  Age, yr                            56.8 ± 20.2        59.6 ± 17.6       0.077
  Gender, man                        159 (54.6)         147 (52.5)        0.608
  Comorbidities                                                           
   Diabetes mellitus                 36 (12.4)          46 (16.4)         0.167
   Hypertension                      109 (37.5)         123 (43.9)        0.115
   Malignancy                        71 (24.4)          81 (28.9)         0.221
   Dyslipidemia                      73 (25.1)          75 (26.8)         0.643
   Chronic kidney disease            11 (3.8)           19 (6.8)          0.108
   Chronic liver disease             9 (3.1)            9 (3.2)           0.934
   Previous TIA or stroke            26 (8.9)           24 (8.6)          0.878
  Cause of ICU admission                                                  0.545
   Intracranial hemorrhage           89 (30.6)          80 (28.6)         
   TBI                               70 (24.1)          82 (29.3)         
   Subarachnoid hemorrhage           71 (24.4)          71 (25.4)         
   Cerebral infarction               33 (11.3)          22 (7.9)          
   CNS infection                     16 (5.5)           12 (4.3)          
   Other                             12 (4.1)           13 (4.6)          
  GCS on ICU admission               11.5 ± 3.9         11.7 ± 3.7        0.491
  APACHE II score on ICU admission   13.0 ± 6.5         13.0 ± 7.0        0.990

Values are presented as number of patients (%) or mean ± SD.

ICU = intensive care unit, TIA = transient ischemic attack, TBI = traumatic brain injury, CNS = central nervous system, GCS = Glasgow Coma Scale, APACHE = Acute Physiology and Chronic Health Evaluation, SD = standard deviation.

Clinical outcomes
-----------------

There were no significant differences in ICU mortality rate (11.0% vs. 9.6%; *P* = 0.595), hospital mortality rate (14.4% vs. 12.9%, *P* = 0.584), and LOS in the ICU (6.1 ± 7.7 days vs. 7.1 ± 7.9 days; *P* = 0.454) before and after neurointensivist co-management. The duration of mechanical ventilator use were increased after compared to before initiation of neurointensivist co-management (8.7 ± 11.7 days vs. 5.7 ± 4.8 days; *P* = 0.007). Thirty-day mortality rate showed a reducing tendency after compared to before initiation of neurointensivist co-management, but there was no significant difference (10.0% vs. 12.4%, log-rank test; *P* = 0.373; [Fig. 1A](#F1){ref-type="fig"}). Clinical outcomes are shown in [Table 2](#T2){ref-type="table"}.

![Kaplan-Meier 30-day survival analyses before and after neurointensivist co-management in all ICU patients (**A**) and TBI patients (**B**). Black solid line, before neurointensivist co-management; red solid line, after neurointensivist co-management; *P* = 0.373 and *P* = 0.011, respectively, based on log-rank tests.\
ICU = intensive care unit, TBI = traumatic brain injury.](jkms-32-1024-g001){#F1}

###### Clinical outcomes before and after neurointensivist co-management
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  Clinical outcomes                                    Before (n = 291)   After (n = 280)   *P* value
  ---------------------------------------------------- ------------------ ----------------- -----------
  Need for mechanical ventilator                       129 (44.3)         130 (46.4)        0.615
  Need for renal replacement therapy                   9 (3.1)            17 (6.1)          0.088
  Need for invasive ICP monitoring                     61 (21.0)          66 (23.6)         0.454
  Duration of mechanical ventilator, day               5.7 ± 4.8          8.7 ± 11.7        0.007
  Duration of renal replacement therapy, day           5.8 ± 3.1          6.5 ± 4.1         0.638
  Duration of invasive ICP monitoring, day             7.6 ± 9.2          7.5 ± 5.3         0.907
  ICU mortality according to causes of ICU admission                                        0.451
   TBI                                                 16 (50.0)          7 (25.9)          
   Intracranial hemorrhage                             8 (25.0)           10 (37.0)         
   Subarachnoid hemorrhage                             5 (15.6)           7 (25.9)          
   Cerebral infarction                                 2 (6.2)            2 (7.4)           
   Other                                               1 (3.1)            1 (3.7)           
  Outcomes                                                                                  
   ICU mortality                                       32 (11.0)          27 (9.6)          0.595
   30-day mortality                                    36 (12.4)          28 (10.0)         0.369
   Hospital mortality                                  42 (14.4)          36 (12.9)         0.584
   LOS in ICU, day                                     6.1 ± 7.7          7.1 ± 7.9         0.454
   LOS in hospital, day                                65.4 ± 269.8       51.1 ± 123.5      0.417

Values are presented as number of patients (%) or mean ± SD.

ICP = intracranial pressure, TBI = traumatic brain injury, LOS = length of stay, ICU = intensive care unit, SD = standard deviation.

TBI was the most common cause of death in the ICU (39.0%). Twenty-three patients died of TBI during treatment in ICU. Of these patients, 16 patients were dead before neurointensivist co-management. Ten patients died of severe brain damage, while 6 patients died of medical and other problems (3 septic shock, 2 multiorgan failure, and 1 tension pneumothorax). Among 7 TBI patients who were dead after neurointensivist co-management, 6 patients died of severe brain damage and only 1 patient died of multiorgan failure. There were no significant differences in IMPACT prognostic models and APACHE II score before and after neurointensivist co-management ([Table 3](#T3){ref-type="table"}). However, there were significant differences in the ICU mortality rate (22.9% vs. 8.5%; *P* = 0.014) and hospital mortality rate (28.6% vs. 14.6%; *P* = 0.036) in TBI patients before and after co-management ([Table 3](#T3){ref-type="table"}). The 30-day mortality rate was significantly lower after compared to before initiation of neurointensivist co-management (11.0% vs. 27.1%, log-rank test; *P* = 0.011; [Fig. 1B](#F1){ref-type="fig"}). In addition, there was significantly lower in ICU mortality among the TBI patients with GCS below 12 after compared to before initiation of neurointensivist co-management (17.1% vs. 38.5%; *P* = 0.031). Neurointensivist co-management was an independent predictor of an improved ICU mortality rate in TBI patients (adjusted OR, 0.160; 95% CI, 0.028--0.905).

###### Baseline characteristics and clinical outcomes of TBI patients before and after neurointensivist co-management
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  Parameters                                   Before (n = 70)   After (n = 82)   *P* value
  -------------------------------------------- ----------------- ---------------- -----------
  Age, yr                                      57.0 ± 25.8       64.2 ± 15.2      0.045
  Gender, man                                  48 (68.6)         53 (68.3)        0.971
  Comorbidities                                                                   
   Diabetes mellitus                           12 (17.1)         23 (28.0)        0.111
   Hypertension                                21 (30.0)         37 (45.1)        0.056
   Malignancy                                  13 (18.6)         18 (22.0)        0.606
   Dyslipidemia                                12 (17.1)         29 (35.4)        0.012
   Chronic kidney disease                      2 (2.9)           8 (9.8)          0.109
   Chronic liver disease                       2 (2.9)           6 (7.3)          0.289
   Previous TIA or stroke                      6 (8.6)           2 (2.4)          0.144
  IMPACT                                                                          
   Core model                                  5.9 ± 4.3         5.6 ± 3.5        0.669
   Extended model^\*^                          8.1 ± 6.3         8.3 ± 4.7        0.807
   Lab model^†^                                11.6 ± 7.2        11.8 ± 5.2       0.836
  Marshall CT grade                            3.7 ± 1.7         4.1 ± 1.5        0.137
  APACHE II score on ICU admission             14.9 ± 7.7        14.5 ± 6.2       0.635
  GCS on ICU admission                         10.2 ± 4.3        11.1 ± 3.8       0.162
  Need for mechanical ventilator               40 (57.1)         42 (51.2)        0.465
  Need for renal replacement therapy           1 (1.4)           8 (9.8)          0.030
  Need for invasive ICP monitoring             6 (8.6)           12 (14.6)        0.249
  Need for vasopressor                         12 (17.1)         18 (22.0)        0.458
  Mean blood pressure on ICU admission, mmHg   77.5 ± 10.3       76.7 ± 9.7       0.634
  Duration of mechanical ventilator, day       4.9 ± 4.2         13.2 ± 14.7      0.001
  Duration of renal replacement therapy, day   2.0               9.4 ± 3.9        \-
  Duration of invasive ICP monitoring, day     7.3 ± 4.0         5.3 ± 4.8        0.394
  Outcomes                                                                        
   ICU mortality                               16 (22.9)         7 (8.5)          0.014
   30-day mortality                            19 (27.1)         9 (11.0)         0.010
   Hospital mortality                          20 (28.6)         12 (14.6)        0.036
   LOS in ICU, day                             5.2 ± 7.4         7.1 ± 10.4       0.197
   LOS in hospital, day                        27.4 ± 26.3       60.3 ± 91.4      0.002

Values are presented as number of patients (%) or mean ± SD.

TBI = traumatic brain injury, TIA = transient ischemic attack, IMPACT = International Mission for Prognosis and Analysis of Clinical Trials, CT = computed tomography, APACHE = Acute Physiology and Chronic Health Evaluation, GCS = Glasgow Coma Scale, LOS = length of stay, ICU = intensive care unit, ICP = intracranial pressure, SD = standard deviation.

^\*^Core plus hypoxia, hypotension, and CT characteristics. ^†^Extended plus glucose and hemoglobin.

The clinical outcomes were similar after compared to before initiation of neurointensivist co-management in patients with intracranial hemorrhage, subarachnoid hemorrhage, and cerebral infarction. There were no significant differences in ICU mortalities, 30-day mortality, and LOS in the ICU in these patients before and after neurointensivist co-management.

DISCUSSION
==========

This study is the first report of the role of neurointensivists and clinical outcomes after initiation of neurointensivist co-management in NSICUs in Korea. Intracranial hemorrhage and TBI were the most frequent reasons for ICU admission. Approximately half of the ICU patients suffered from these diseases. TBI was the most common cause of death in the ICU. There were no significant differences in mortality rates and LOS in the ICU before and after initiation of neurointensivist co-management in this study. However, the ICU and 30-day mortality rates were significantly lower among the TBI patients after compared to before initiation of neurointensivist co-management.

Neurointensivists are critical care physicians specifically focused on the management of neurocritically ill patients ([@B6][@B7][@B8]). The birth of neurocritical care stemmed from the appreciation that an already affected brain (primary injury) is greatly influenced by systemic alterations that may adversely affect its function (secondary injury). Neurointensivist are specially trained to recognize and treat such injuries ([@B6][@B7]). Because of this increasing complexity of acute care of the neurocritically ill patient, a multidisciplinary approach to the neurocritical care is necessary. Neurointensivists have to work in collaboration with neurosurgeons and other physicians in coordinating acute care protocols, decisions about advanced neuromonitoring, and other aspects of care ([@B6]).

Neurointensivists have emerged in the last decades as specialists trained to manage all aspects of the ICU stay of neurocritically ill patients in the USA ([@B2]). The institution of a neurointensivist-led team model has been reported to improve outcomes, including decreased mortality rates, shortened length of ICU and hospital stay in neurocritically ill patients with TBI, intracranial hemorrhage, and subarachnoid hemorrhage ([@B2][@B3][@B11]). However, there are only a few neurointensivists in Korea. In addition, neuroscience ICUs, which are operated jointly by neurology and neurosurgery, are uncommon ([@B17]). NSICUs operate independently in most tertiary hospitals in Korea ([@B17]). Furthermore, it is very rare to treat neurocritically ill patients in cooperation between neurosurgical teams and neurointensivists in NSICUs. The concept of neurocritical care emerged in Korea only recently. Intensivists in general medical and surgical ICUs also emerged recently, and so the current status of critical care in Korea is not comparable to that of advanced countries ([@B18]). A nationwide survey of ICUs was performed in 2014, and only 17.3% of ICUs had intensive care specialists with a 5-day work week ([@B18][@B19]).

In general, adequate staffing showed favorable effects on ICU stay and decreased use of resources ([@B18]). However, there was no significant difference in length of ICU stay before and after initiation of neurointensivist co-management in this study. Furthermore, duration of mechanical ventilator showed an increasing trend after neurointensivist co-management. Neurosurgeons usually determined whether to transfer patients from the NSICU to general wards in this study, usually after confirming that the patients had fully recovered. Some patients stayed in ICU over a weekend, during which time the neurosurgeon wanted to monitor them closely. The indications for which the neurosurgical patients were transferred from the ICU to general wards differed among the neurosurgeons. If the patients exhibited medical problems such as sepsis, pneumonia, acute respiratory distress syndrome, and hemodynamic instability, they were transferred to internal medicine and treated in the medical ICU before neurointensivist co-management. However, after initiation of co-management many of the patients with medical problems were treated by a neurointensivist in the NSICU. Neurointensivist were sometimes consulted for patients with respiratory and hemodynamic instability in the neurosurgery general ward. Therefore, these special situations might be associated with the length of ICU stay and prolonged duration of mechanical ventilator use.

The overall mortality rate of TBI patients improved after neurointensivist co-management. Mortality according to medical problems was decreased after neurointensivist co-management in TBI patients. This change was associated with effort of neurointensivist. Furthermore, brain death according to severe brain damage was also decreased after neurointensivist co-management. The clinical outcomes of TBI patients depend on both primary and secondary brain insults ([@B20]). Aggressive management of secondary brain injury is associated with a good neurological outcome ([@B20]). Furthermore, TBI may be accompanied by hemodynamic instability for various reasons ([@B21][@B22]). Hemodynamic stability is important to maintain the capacity for vascular autoregulation, either globally or locally, in severe TBI patients ([@B21][@B22]). Therefore, collaboration between neurointensivists and neurosurgeons is necessary. Indeed, co-management with a neurointensivist improved the clinical outcomes of TBI ([@B3][@B20][@B21]). Interestingly, emergency operations on TBI patients are usually performed by young neurosurgeons in Korea. Young neurosurgeons may not have sufficient time to treat neurocritically ill patients. Therefore, young neurosurgeons need to collaborate with neurointensivists. Indeed, young neurosurgeons discussed their patients with the neurointensivist more actively than did senior members of the faculty in our hospital.

Several neuroscience ICU models such as "open" vs. "semi-closed" and "closed" ICU practice models are available ([@B11]). Korea contains all of these types; our NSICU is similar to an open ICU model. It is important to collaborate with each physician in an open ICU model. Because of the increased complexity of neurological diseases, a multidisciplinary approach to neurocritical care is required ([@B8]). Neurointensivists have to collaborate with neurosurgeons, neurologists and other physicians for decisions regarding acute care protocols in neuroscience ICU ([@B8]). However, it is not easy to cooperate with all neurosurgeons. While some neurosurgeons were cooperative, others were not. A neurointensivist alone cannot treat all patients and neurosurgeons cannot stay in the ICU all day. Thus sharing of opinions and collaboration between neurosurgeons and neurointensivists are required in treatment of neurocritically ill patients. Neurointensivists can manage not only neurological diseases but also all aspects of the critical care. They can rapidly respond to emerging problems in neuroscience ICUs. In the near future, full-time employment of neurointensivists can improve clinical outcome in neuroscience ICUs in Korea.

This study had several limitations. It was a retrospective review of medical records. Our study may not be broadly applicable to other centers at which no neurointensivists are available because our study was conducted at a single tertiary institution with a specialized NSICU for neurosurgical and neurocritically ill patients. The neurointensivist in our hospital is a neurologist and trained to manage all aspects of critically ill patients in medical and surgical ICUs. The treatment tendency of this neurointensivist might have influenced the clinical outcomes in neurocritically ill patients. The neurosurgical team discussed the treatment plans of all ICU patients with the neurointensivist, but it was sometimes difficult to cooperate with the neurosurgeon and the neurointensivist because collaborative work was just begun. Because of these situations, the role of neurointensivist might be limited. These special situations were different from other NSICUs in Korea. Therefore, selection bias and other confounding factors might have been influenced. Prospective large-scale studies are needed to evaluate the impact of neurointensivists in the management of neurocritically ill patients in Korea.

In conclusion, although overall outcomes were not significantly different after neurointensivist co-management, the ICU and 30-day mortality rates of TBI patients were significantly reduced. A multidisciplinary approach is important in treatment of neurocritically ill patients because of the increasing complexity of neurological problems. Therefore, collaboration between neurosurgeons and neurointensivists is necessary. In the near future, this multidisciplinary team-based approach involving neurointensivists and neurosurgeons working together will improve the outcome of neurocritically ill patients in Korea.
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